Deutsche Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$60.6M Sell
1,665,852
-35,641
-2% -$1.3M 0.02% 565
2025
Q1
$61.6M Buy
1,701,493
+8,385
+0.5% +$304K 0.02% 563
2024
Q4
$71.2M Buy
1,693,108
+4,137
+0.2% +$174K 0.03% 551
2024
Q3
$93.8M Sell
1,688,971
-93,369
-5% -$5.19M 0.04% 420
2024
Q2
$73.3M Buy
1,782,340
+575,115
+48% +$23.6M 0.03% 446
2024
Q1
$56.4M Buy
1,207,225
+34,359
+3% +$1.6M 0.03% 524
2023
Q4
$56.1M Buy
1,172,866
+225,134
+24% +$10.8M 0.03% 488
2023
Q3
$33.8M Buy
947,732
+60,001
+7% +$2.14M 0.02% 564
2023
Q2
$41M Sell
887,731
-490
-0.1% -$22.6K 0.02% 560
2023
Q1
$35.6M Buy
888,221
+26,542
+3% +$1.06M 0.02% 607
2022
Q4
$39.9M Buy
861,679
+32,012
+4% +$1.48M 0.02% 576
2022
Q3
$34.4M Buy
829,667
+341,959
+70% +$14.2M 0.02% 612
2022
Q2
$29.1M Buy
487,708
+122,180
+33% +$7.29M 0.02% 684
2022
Q1
$26.5M Sell
365,528
-89,805
-20% -$6.52M 0.01% 761
2021
Q4
$38.3M Buy
455,333
+99,547
+28% +$8.37M 0.02% 664
2021
Q3
$32.1M Sell
355,786
-23,095
-6% -$2.08M 0.02% 737
2021
Q2
$36.1M Sell
378,881
-47,965
-11% -$4.57M 0.02% 707
2021
Q1
$48.6M Sell
426,846
-33,358
-7% -$3.8M 0.03% 597
2020
Q4
$63.7M Buy
460,204
+28,343
+7% +$3.92M 0.04% 426
2020
Q3
$35.5M Sell
431,861
-49,607
-10% -$4.08M 0.02% 543
2020
Q2
$37.7M Buy
481,468
+6,610
+1% +$517K 0.03% 517
2020
Q1
$21.1M Buy
474,858
+36,989
+8% +$1.64M 0.02% 629
2019
Q4
$18.7M Sell
437,869
-24,508
-5% -$1.05M 0.01% 812
2019
Q3
$19.8M Sell
462,377
-87,618
-16% -$3.75M 0.01% 783
2019
Q2
$34.9M Buy
549,995
+98,699
+22% +$6.27M 0.02% 722
2019
Q1
$31.3M Buy
451,296
+264,422
+141% +$18.3M 0.02% 781
2018
Q4
$8.12M Sell
186,874
-110,679
-37% -$4.81M 0.01% 1441
2018
Q3
$22.7M Sell
297,553
-29,467
-9% -$2.25M 0.01% 1058
2018
Q2
$25.1M Sell
327,020
-37,149
-10% -$2.86M 0.01% 1042
2018
Q1
$18.6M Buy
364,169
+180,492
+98% +$9.2M 0.01% 1164
2017
Q4
$8.52M Sell
183,677
-178,443
-49% -$8.27M 0.01% 1611
2017
Q3
$19.3M Buy
362,120
+154,793
+75% +$8.24M 0.01% 1057
2017
Q2
$12.9M Buy
207,327
+54,237
+35% +$3.37M 0.01% 1213
2017
Q1
$10.4M Sell
153,090
-22,193
-13% -$1.5M 0.01% 1240
2016
Q4
$12.3M Sell
175,283
-38,982
-18% -$2.74M 0.01% 1134
2016
Q3
$15.2M Buy
214,265
+55,799
+35% +$3.96M 0.01% 1051
2016
Q2
$7.75M Sell
158,466
-57,811
-27% -$2.83M 0.01% 1463
2016
Q1
$13.7M Buy
216,277
+50,751
+31% +$3.21M 0.01% 1088
2015
Q4
$18.6M Buy
165,526
+59,173
+56% +$6.64M 0.01% 951
2015
Q3
$10.2M Buy
106,353
+43,835
+70% +$4.22M 0.01% 1269
2015
Q2
$6.4M Buy
62,518
+11,515
+23% +$1.18M ﹤0.01% 1630
2015
Q1
$3.17M Buy
51,003
+50,968
+145,623% +$3.16M ﹤0.01% 2105
2014
Q4
$1K Sell
35
-2,650
-99% -$75.7K ﹤0.01% 5405
2014
Q3
$150K Buy
2,685
+1,145
+74% +$64K ﹤0.01% 4022
2014
Q2
$69K Sell
1,540
-20,300
-93% -$910K ﹤0.01% 4442
2014
Q1
$1.07M Buy
+21,840
New +$1.07M ﹤0.01% 2819